AKT1 and breast carcinoma: To further determine whether the activation of AKT-mTOR pathway contributes to the effect of LIF on breast cancer tumorigenesis and metastasis, above-mentioned breast cancer cell lines were treated with LIF along with or without wortmannin to block AKT pathway.